This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations in Pediatric Healthcare: The Invention of Gatifloxacin by Luigi Esposito
Introduction: Luigi Esposito, an inventive mind based in Howell, NJ, has made significant contributions to pediatric healthcare through his innovation in the formulation of gatifloxacin. This invention addresses the challenges associated with the bitter taste of this quinolone antibacterial, making it more suitable for children.
Latest Patents: Luigi's noteworthy patent revolves around a pediatric formulation of gatifloxacin. This invention effectively taste-masks gatifloxacin, allowing it to be utilized in pediatric formulations. The unique aspect of this invention is the creation of a crystalline co-precipitate of gatifloxacin combined with stearic acid and palmitic acid in specific weight ratios. This formulation not only successfully masks the bitter taste of gatifloxacin but also ensures its availability for absorption from the stomach over a typical treatment cycle of fourteen days.
Career Highlights: Luigi Esposito is associated with Bristol-Myers Squibb Company, a global leader in pharmaceutical innovation. His work in enhancing formulations that cater to the needs of pediatric patients exemplifies his commitment to health advancements. Through this patent, he has made a tangible impact on medical practices surrounding antibiotic administration to children.
Collaborations: Throughout his career, Luigi has collaborated with esteemed professionals such as Krishnaswamy Srinivas Raghavan and Sunanda A Ranadive. Their joint efforts in pharmaceutical research reflect a shared vision for improving drug formulations and expanding therapeutic options for pediatric patients.
Conclusion: The innovative work of Luigi Esposito serves as a testament to the impact that targeted inventions can have in improving healthcare outcomes for children. His patent on the pediatric formulation of gatifloxacin highlights the vital role of inventors in addressing specific medical challenges, paving the way for a healthier future for young patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
